Pancreatic cancer has been called the silent cancer because it is difficult to detect and almost impossible to treat successfully.
Now scientists in Cambridge are testing a new drug combination and it's giving fresh hope to patients.
Breakthroughs in the treatment of more common forms means that 80 out of every 100 breast cancer patients now survive. But it's still only 3 in 100 when it comes to pancreatic cancer. In this region alone 412 people were diagnosed with the disease in a year, 385 died.
Campaigners have welcomed a new drug trial in Cambridge but say more must be done.
Click below to watch a report by ITV News Anglia's Claire McGlasson